Clinical Trial

Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A randomized, parallel, double-blind, controlled, multicenter clinical trial with two intervention arms. Two groups of participants will be included, both receiving a therapeutic exercise intervention and an educational session on the importance of proper breathing over a 6-week period. One of the groups will additionally perform a home-based controlled breathing exercise protocol. Pre- and post-intervention assessments (6 weeks) will be conducted, along with a follow-up evaluation 4 weeks after completion of the intervention. The goal is to determine the effectiveness of adding a controlled breathing exercise program to a therapeutic exercise intervention on somatic symptoms in individuals with multiple myeloma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-17.
Trial Details
NCT Number NCT07312942
Lead Sponsor Universidad Complutense de Madrid
Conditions Multiple Myeloma, Breathing Techniques, Breathing Exercises, Exercise Activity, Diaphragmatic Breathing
Enrollment 32 participants
Start Date 2026-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-20